Bank of Hawaii trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.2% in the first quarter, according to its most recent filing with the SEC. The firm owned 13,017 shares of the medical research company’s stock after selling 164 shares during the period. Bank of Hawaii’s holdings in Thermo Fisher Scientific were worth $3,563,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in the company. Capital Financial Planning LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $27,000. Hanson McClain Inc. increased its position in shares of Thermo Fisher Scientific by 263.9% during the 4th quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock worth $29,000 after purchasing an additional 95 shares in the last quarter. Truvestments Capital LLC acquired a new stake in shares of Thermo Fisher Scientific during the 1st quarter worth about $29,000. Capital Investment Advisory Services LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $35,000. Finally, Liberty Wealth Management LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $35,000. 87.96% of the stock is owned by institutional investors.

In other news, CEO Marc N. Casper sold 50,713 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $273.21, for a total transaction of $13,855,298.73. Following the completion of the sale, the chief executive officer now owns 302,193 shares in the company, valued at approximately $82,562,149.53. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director C Martin Harris sold 275 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $270.73, for a total transaction of $74,450.75. Following the sale, the director now owns 6,433 shares of the company’s stock, valued at approximately $1,741,606.09. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,488 shares of company stock valued at $14,600,474. 0.45% of the stock is owned by corporate insiders.

TMO opened at $285.05 on Wednesday. The company has a quick ratio of 1.16, a current ratio of 1.69 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $112.67 billion, a price-to-earnings ratio of 25.63, a P/E/G ratio of 1.85 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 1-year low of $202.83 and a 1-year high of $288.07.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, April 24th. The medical research company reported $2.81 earnings per share for the quarter, beating the consensus estimate of $2.74 by $0.07. The firm had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Thermo Fisher Scientific had a net margin of 12.89% and a return on equity of 17.06%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company posted $2.50 EPS. As a group, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 12.2 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 16th. Stockholders of record on Friday, June 14th will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend is Thursday, June 13th. Thermo Fisher Scientific’s dividend payout ratio is 6.83%.

TMO has been the subject of a number of recent analyst reports. Barclays increased their target price on shares of Thermo Fisher Scientific from $295.00 to $300.00 and gave the stock an “overweight” rating in a research report on Monday, March 18th. Deutsche Bank raised their price objective on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, March 22nd. UBS Group raised their price objective on shares of Thermo Fisher Scientific to $305.00 and gave the company a “buy” rating in a research report on Monday, March 25th. BTIG Research raised their price objective on shares of Thermo Fisher Scientific to $310.00 and gave the company a “buy” rating in a research report on Tuesday, March 26th. Finally, Robert W. Baird raised their price objective on shares of Thermo Fisher Scientific from $270.00 to $288.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $295.92.

COPYRIGHT VIOLATION WARNING: This article was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://theolympiareport.com/2019/06/12/bank-of-hawaii-has-3-56-million-stake-in-thermo-fisher-scientific-inc-nysetmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: What are no-load funds?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.